4//SEC Filing
SALIX PHARMACEUTICALS LTD 4
Accession 0001209191-13-032529
CIK 0001009356operating
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:15 PM ET
Size
9.5 KB
Accession
0001209191-13-032529
Insider Transaction Report
Form 4
D ALONZO THOMAS
Director
Transactions
- Tax Payment
Common Stock
2013-06-13$65.04/sh−1,040$67,642→ 87,524 total
Holdings
- 260(indirect: By LP)
Common Stock
- 6,500(indirect: By Spouse)
Common Stock
- 15,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying) - 1,080(indirect: By Trust)
Common Stock
- 22,500
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (22,500 underlying)
Footnotes (3)
- [F1]Does not represent a sale in the market; represents a forfeiture of shares to the Issuer in order to pay tax withholding upon vesting of restricted stock.
- [F2]The shares are held by the Rachel L. D'Alonzo Rev Trust U/A DTD 10/24/2001 for which the Reporting Person serves as co-trustee.
- [F3]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001009356
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:15 PM ET
- Size
- 9.5 KB